Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
The deal has already been approved by the boards of directors from both companies.
Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.
Shockwave’s technology is used to treat coronary artery and peripheral artery disease.
The company’s revenue jumped 49% last year to $730 million.
Related articles:
Related suggestion:
Xi Meets Blinken in BeijingXi Meets with Mongolian PMExplainer: Learn About China from Continuity of Chinese CivilizationKazakhstan tourism year in China launched in BeijingXi, Ramaphosa Hold Phone Talks over Bilateral Ties, Ukraine CrisisXi Stresses Cultural Advancement in Letter to ForumFourth Volume of 'Xi Jinping: The Governance of China' Published in More LanguagesXi Stresses Cultural Advancement in Letter to ForumFreight increases on ChinaFourth Volume of 'Xi Jinping: The Governance of China' Published in More Languages
2.5714s , 6495.2578125 kb
Copyright © 2024 Powered by J&J to pump another $13B into its MedTech business with Shockwave deal ,Worldly Wisdom news portal